Separate terms with OR to return results that match either term.
 
Clear All

10,000 Matching ResultsExport these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength (Ascending) SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
55289-0603-30 55289-0603 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Dec. 23, 2009 Nov. 23, 2021 No Longer Used
55289-0603-90 55289-0603 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Dec. 23, 2009 Nov. 23, 2021 No Longer Used
61919-0198-30 61919-0198 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Nov. 25, 2015 In Use
61919-0198-60 61919-0198 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Aug. 12, 2019 In Use
63629-2766-01 63629-2766 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral March 14, 1996 Dec. 30, 2017 No Longer Used
63629-6467-01 63629-6467 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Sept. 4, 2015 Jan. 11, 2022 No Longer Used
69189-0899-01 69189-0899 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Oct. 29, 2015 May 24, 2017 No Longer Used
54868-5443-02 54868-5443 Anagrelide Hydrochloride Anagrelide Hydrochloride 0.5 mg/1 Ancillary Therapy Platelet-Reducing Agent PDE-3 Inhibitor Oral July 19, 2007 In Use
62856-0796-01 62856-0796 Netupitant and Palonosetron Akynzeo 300.0 mg/1, 0.5 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Anatagonist/Substance P/Neurokinin 1 Oral Oct. 13, 2014 May 31, 2018 No Longer Used
62856-0796-04 62856-0796 Netupitant and Palonosetron Akynzeo 300.0 mg/1, 0.5 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Anatagonist/Substance P/Neurokinin 1 Oral Oct. 13, 2014 Oct. 13, 2014 No Longer Used

Found 10,000 results in 4 millisecondsExport these results